Literature DB >> 11836570

Molecular cloning and characterization of human GIPC2, a novel gene homologous to human GIPC1 and Xenopus Kermit.

Hiroyuki Kirikoshi1, Masaru Katoh.   

Abstract

PDZ-domain protein GIPC1/GIPC interacts with GTPase-activating protein RGS-GAIP, TGFbeta type III receptor, and integrin alpha6A subunit. Kermit, a Xenopus orthologue of human GIPC1, interacts with some class of WNT receptor. In this study, we identified a novel GIPC1-related gene in human genome by using bioinformatics, and isolated GIPC2 cDNAs by using cDNA-PCR. GIPC2 encoded a 315-amino-acid protein with a central PDZ domain, which showed 62.0% total-amino-acid identity with GIPC1. Both GIPC2 gene on human chromosome 1 and GIPC1 gene on human chromosome 19p13.1 were found to consist of 6 exons. Exon-intron structures of GIPC2 gene and GIPC1 gene were well conserved. GIPC2 mRNA was relatively highly expressed in ascending colon, followed by kidney and pancreas. Among 3.7-, 2.6-, and 1.7-kb GIPC2 mRNAs generated due to alternative polyadenylation, 2.6-kb GIPC2 mRNA was the major GIPC2 transcript in adult kidney. Expression of GIPC2 mRNA was significantly down-regulated in 6 out of 14 cases of primary kidney tumors, in 5 out of 11 cases of primary colon tumors, and in 1 out of 7 cases of primary rectal tumors. Because GIPC2 might bind to TGFbeta type III receptor or some class of WNT receptor, just like GIPC1 or Kermit, down-regulation of GIPC2 mRNA in human primary tumors might lead to interference of TGFbeta signaling or some class of WNT signaling. This is the first report on molecular cloning of GIPC2, the second member of the GIPC gene family, which is down-regulated in human primary kidney and colorectal tumors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836570

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  8 in total

1.  Truncation of histone H2A's C-terminal tail, as is typical for Ni(II)-assisted specific peptide bond hydrolysis, has gene expression altering effects.

Authors:  Aldona A Karaczyn; Robert Y S Cheng; Gregory S Buzard; James Hartley; Dominic Esposito; Kazimierz S Kasprzak
Journal:  Ann Clin Lab Sci       Date:  2009       Impact factor: 1.256

2.  Human papillomavirus type 18 E6 protein binds the cellular PDZ protein TIP-2/GIPC, which is involved in transforming growth factor beta signaling and triggers its degradation by the proteasome.

Authors:  Arnaud Favre-Bonvin; Caroline Reynaud; Carole Kretz-Remy; Pierre Jalinot
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Downregulation of heat shock protein B8 decreases osteogenic differentiation potential of dental pulp stem cells during in vitro proliferation.

Authors:  M Flanagan; C Li; M A Dietrich; M Richard; S Yao
Journal:  Cell Prolif       Date:  2017-12-20       Impact factor: 6.831

Review 4.  Functional proteomics, human genetics and cancer biology of GIPC family members.

Authors:  Masaru Katoh
Journal:  Exp Mol Med       Date:  2013-06-07       Impact factor: 8.718

5.  GIPC2 is an endocrine-specific tumor suppressor gene for both sporadic and hereditary tumors of RET- and SDHB-, but not VHL-associated clusters of pheochromocytoma/paraganglioma.

Authors:  Yeqing Dong; Yongsheng Huang; Chengyan Fan; Liang Wang; Ran Zhang; Wenhua Li; Zhengguang Guo; Dong Wang; Zhi Zheng
Journal:  Cell Death Dis       Date:  2021-05-04       Impact factor: 8.469

6.  GIPC2 interacts with Fzd7 to promote prostate cancer metastasis by activating WNT signaling.

Authors:  Liang Wang; Jiayi Wang; Xiaolin Yin; Xin Guan; Ying Li; Chenqi Xin; Jing Liu
Journal:  Oncogene       Date:  2022-03-28       Impact factor: 8.756

Review 7.  Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis.

Authors:  Masaru Katoh
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 6.692

8.  Efficient test for nonlinear dependence of two continuous variables.

Authors:  Yi Wang; Yi Li; Hongbao Cao; Momiao Xiong; Yin Yao Shugart; Li Jin
Journal:  BMC Bioinformatics       Date:  2015-08-19       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.